Postoperative adjuvant adoptive immunotherapy with lymph node-LAK cells and IL-2 for pathologic stage I non-small cell lung cancer-Reference-Cited by-同舟云学术

Postoperative adjuvant adoptive immunotherapy with lymph node-LAK cells and IL-2 for pathologic stage I non-small cell lung cancer

Published:1999-12 Issue:3 Volume:26 Page:143-148
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Yano Tokujiro,Sugio Kenji,Yamazaki Koji,Kase Shinichiro,Yamaguchi Masafumi,Ondo Kaoru,Yoshino Ichiro,Sugimachi Keizo

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer;Rosenberg;New. Engl. J. Med.,1985

2. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone;Rosenberg;New. Engl. J. Med.,1987

3. Constant infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer;West;New. Engl. J. Med.,1987

4. Interleukin 2 and lymphokine-activated killer cell therapy: analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen;Clark;Cancer. Res.,1990

5. Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a national biotherapy study group trial;Dillman;J. Clin. Oncol.,1991

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adoptive cell therapies in thoracic malignancies;Cancer Immunology, Immunotherapy;2022-02-07

2. Prospective Analyses of Cytokine Mediation of Sleep and Survival in the Context of Advanced Cancer;Psychosomatic Medicine;2018-06

3. Adoptive immunotherapy shows encouraging benefit on non-small cell lung cancer: a systematic review and meta-analysis;Oncotarget;2017-07-19

4. Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date;OncoTargets and Therapy;2016-09

5. Emerging Immunotherapies in the Treatment of Non–small Cell Lung Cancer (NSCLC);American Journal of Clinical Oncology;2015-08